poisar

Stocks · News reference

Innventure (INV) Stock Falls 45% After Hours: What's Going On?

Tanya Rawat

Innventure stock falls 45% after hours as Accelsius suspends 2026 revenue and cash flow expectations.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

INV
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Kaplan Fox & Kilsheimer Llp

    Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) Who Suffered Losses to Contact the Firm Before November 2, 2026

    Kaplan Fox has filed class action lawsuits against three companies: Hims & Hers for allegedly failing to disclose immediate prescription charges, sharing health data with third parties, and making subscription cancellations difficult; Hyliion Holdings for undisclosed issues during May-June 2026; and Innventure for regulatory concerns from November 2025 to August 2026. Investors with losses are encouraged to contact the firm before respective deadlines.

    HIMSHYLNINV
  3. The Law Offices Of Frank R. Cruz

    Securities Fraud Investigation Into Innventure, Inc. (INV) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

    Innventure, Inc. reported disappointing Q2 2026 results on August 13, 2026, missing earnings and revenue consensus estimates significantly and suspending its 2026 guidance for its Accelsius division. The company cited challenges in the AI infrastructure market including power availability and GPU access constraints for smaller companies. The stock fell 55.1% to $1.62 per share on August 14, 2026, prompting a securities fraud investigation.

    INV